当前位置: X-MOL 学术IEEE Spectr. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
AI takes its best shot: What AI can—and can't—do in the race for a coronavirus vaccine - [Vaccine]
IEEE Spectrum ( IF 3.1 ) Pub Date : 2020-09-24 , DOI: 10.1109/mspec.2020.9205545
Emily Waltz

IN AN ACHIEVEMENT that would have startled biomedical researchers merely a year ago, vaccines against COVID-19 were already being tested in humans this past March, less than three months after the initial outbreak was identified in China. Many of those vaccines owed their speedy start to the power of artificial intelligence (AI). • The feat is a promising and remarkable turn in the 200-year-plus history of immunization. The experience may revolutionize the way vaccines are created, potentially saving countless lives in epidemics yet to come. • As of early September, there were 34 vaccine candidates being tested in humans, according to the World Health Organization (WHO). Another 145 candidates were being tested in animals or in the lab, says WHO, which keeps a running worldwide list. Those are astonishing numbers, considering that less than a year ago no one had heard of the novel coronavirus, now known as SARS-CoV-2, which causes the respiratory disease COVID-19. It typically takes many years, or even decades, to develop a vaccine; until now, the speed record was held by the mumps vaccine, which went from a collected sample to a marketed product in about four years.
更新日期:2020-09-25
down
wechat
bug